These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 2535782)
21. Presence of a 1,25-dihydroxy-vitamin D3 receptor in chick skeletal muscle myoblasts. Boland R; Norman A; Ritz E; Hasselbach W Biochem Biophys Res Commun; 1985 Apr; 128(1):305-11. PubMed ID: 2985076 [TBL] [Abstract][Full Text] [Related]
22. Induction of the differentiation of HL-60 promyelocytic leukemia cells by curcumin in combination with low levels of vitamin D3. Sokoloski JA; Shyam K; Sartorelli AC Oncol Res; 1997; 9(1):31-9. PubMed ID: 9112258 [TBL] [Abstract][Full Text] [Related]
23. Development of receptors for leukotriene B4 on HL-60 cells induced to differentiate by 1 alpha,25-dihydroxyvitamin D3. Goldman DW; Olson DM; Payan DG; Gifford LA; Goetzl EJ J Immunol; 1986 Jun; 136(12):4631-6. PubMed ID: 3011899 [TBL] [Abstract][Full Text] [Related]
24. A 1,25-dihydroxyvitamin D3 receptor-like protein in mammalian and avian liver nuclei. Duncan WE; Whitehead D; Wray HL Endocrinology; 1988 Jun; 122(6):2584-9. PubMed ID: 2836167 [TBL] [Abstract][Full Text] [Related]
25. Functional defect of variant clones of a human myeloid leukemia cell line (HL-60) resistant to 1 alpha,25-dihydroxyvitamin D3. Kuribayashi T; Tanaka H; Abe E; Suda T Endocrinology; 1983 Dec; 113(6):1992-8. PubMed ID: 6315339 [TBL] [Abstract][Full Text] [Related]
26. Specificity of steroid binding in New World primate B95-8 cells with a vitamin D-resistant phenotype. Gacad MA; Adams JS Endocrinology; 1992 Dec; 131(6):2581-7. PubMed ID: 1446602 [TBL] [Abstract][Full Text] [Related]
27. Properties of the estrogen receptor in the human oviduct and its interaction with ethinylestradiol and mestranol in vitro. Muechler EK; Kohler D J Clin Endocrinol Metab; 1980 Nov; 51(5):962-7. PubMed ID: 7419693 [TBL] [Abstract][Full Text] [Related]
28. Specific uptake of 1,25-dihydroxycholecalciferol by human chronic myeloid leukemia cells. Freake HC; Iwasaki J; McCarthy DM Cancer Res; 1984 Aug; 44(8):3627-31. PubMed ID: 6331655 [TBL] [Abstract][Full Text] [Related]
29. Vitamin D resistance and alopecia: a kindred with normal 1,25-dihydroxyvitamin D binding, but decreased receptor affinity for deoxyribonucleic acid. Hirst MA; Hochman HI; Feldman D J Clin Endocrinol Metab; 1985 Mar; 60(3):490-5. PubMed ID: 2982898 [TBL] [Abstract][Full Text] [Related]
30. Physicochemical differences between glucocorticoid-binding components from the corticoid-sensitive and -resistant strains of mouse lymphoma P1798. Stevens J; Stevens YW Cancer Res; 1979 Oct; 39(10):4011-21. PubMed ID: 476639 [TBL] [Abstract][Full Text] [Related]
31. Quantitation of endogenously occupied and unoccupied binding sites for 1,25-dihydroxyvitamin D3 in rat intestine. Massaro ER; Simpson RU; DeLuca HF Proc Natl Acad Sci U S A; 1983 May; 80(9):2549-53. PubMed ID: 6302695 [TBL] [Abstract][Full Text] [Related]
32. Human myeloid leukemia cells metabolize 25-hydroxyvitamin D3 in vitro. Okabe T; Ishizuka S; Fujisawa M; Watanabe J; Takaku F Biochem Biophys Res Commun; 1985 Mar; 127(2):635-41. PubMed ID: 2983728 [TBL] [Abstract][Full Text] [Related]
33. Antagonistic action of novel 1alpha,25-dihydroxyvitamin D(3)-26, 23-lactone analogs on 25-hydroxyvitamin-D(3)-24-hydroxylase gene expression induced by 1alpha,25-dihydroxy-vitamin D(3) in human promyelocytic leukemia (HL-60) cells. Ishizuka S; Miura D; Eguchi H; Ozono K; Chokki M; Kamimura T; Norman AW Arch Biochem Biophys; 2000 Aug; 380(1):92-102. PubMed ID: 10900137 [TBL] [Abstract][Full Text] [Related]
34. Binding of 1,25-dihydroxy-[3H]vitamin D3 in nuclear and cytosol fractions of whole mouse skin in vivo and in vitro. Clemens TL; Horiuchi N; Nguyen M; Holick MF FEBS Lett; 1981 Nov; 134(2):203-6. PubMed ID: 6273232 [No Abstract] [Full Text] [Related]
35. Nuclear uptake of 1,25-dihydroxy[3H]cholecalciferol in dispersed fibroblasts cultured from normal human skin. Eil C; Marx SJ Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2562-6. PubMed ID: 6264480 [TBL] [Abstract][Full Text] [Related]
36. 1,25-Dihydroxyvitamin D3 binding in estrogen-responsive rat breast tumor. Colston K; Wilkinson JR; Coombes RC Endocrinology; 1986 Jul; 119(1):397-403. PubMed ID: 3013595 [TBL] [Abstract][Full Text] [Related]
37. Impaired stimulation of 25-hydroxyvitamin D-24-hydroxylase in fibroblasts from a patient with vitamin D-dependent rickets, type II. A form of receptor-positive resistance to 1,25-dihydroxyvitamin D3. Griffin JE; Zerwekh JE J Clin Invest; 1983 Oct; 72(4):1190-9. PubMed ID: 6313754 [TBL] [Abstract][Full Text] [Related]
38. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues. Norman AW; Sergeev IN; Bishop JE; Okamura WH Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333 [TBL] [Abstract][Full Text] [Related]
39. Abnormal binding of vitamin D receptors to deoxyribonucleic acid in a kindred with vitamin D-dependent rickets, type II. Malloy PJ; Hochberg Z; Pike JW; Feldman D J Clin Endocrinol Metab; 1989 Feb; 68(2):263-9. PubMed ID: 2537329 [TBL] [Abstract][Full Text] [Related]
40. 1,25-dihydroxyvitamin D3 receptors in the seminiferous tubules of the rat testis increase at puberty. Walters MR Endocrinology; 1984 Jun; 114(6):2167-74. PubMed ID: 6327237 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]